08 December 2022
: Case report 
Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report
Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)
Benjamin Peter Michael Gummlich1ABCDEF, Ali Seif Amir Hosseini2BC, Harald Schwörer1ABCDF*DOI: 10.12659/AJCR.938272
Am J Case Rep 2022; 23:e938272
Figure 1. Time course of AST, ALT, and γGT during follow-up. Values of AST, ALT, and γGT are demonstrated during immunosuppressive treatments with prednisolone (Predni), 6-mercaptopurine (6-MP), and budesonide (Bud). > indicates stop of treatment. Further, gangrenous cholecystitis with cholecystectomy occurred (red star).